Related Experiment Video
Updated: Aug 5, 2026

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Faecal Calprotectin: A Non-Invasive Marker for Diagnosing and Monitoring Acute Diverticulitis
Aamer Mohammed1, Yahiya Baig1, Alexandra E Butler2
1School of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen 15503, Bahrain.
Faecal calprotectin (FC) shows promise in diagnosing acute diverticulitis (AD) and assessing disease severity. This non-invasive biomarker can also predict recurrence and monitor treatment effectiveness in patients with diverticular disease.
Area of Science:
- Gastroenterology
- Clinical Biomarkers
- Inflammatory Bowel Disease
Background:
- Acute diverticulitis (AD) is common and frequently recurs.
- Faecal calprotectin (FC) is a biomarker for intestinal inflammation, but its role in diverticulitis needs clarification.
Purpose of the Study:
- Review the evidence for FC's utility in diagnosing and managing diverticular disease (DD) and AD.
- Evaluate FC's role in assessing severity, predicting recurrence, and monitoring treatment response.
Main Methods:
- Conducted a narrative literature review of studies from 2004 to April 2025.
- Searched PubMed, Scopus, and ScienceDirect using keywords for diverticular disease and faecal calprotectin.
- Synthesized original data on FC in DD.
Main Results:
- FC is elevated in AD (556-695 μg/g) and symptomatic uncomplicated diverticular disease (181 μg/g), distinguishing them from functional disorders like IBS (50 μg/g).
- FC correlates with endoscopic severity (48.6% to 93.2% positivity).
- Elevated FC predicts recurrence (87.5% of recurrent cases) and treatment response.
Conclusions:
- FC is a promising non-invasive biomarker for diagnosing AD, assessing severity, predicting recurrence, and monitoring treatment.
- Its ability to detect subclinical inflammation aids risk stratification.
- Further prospective validation is needed for routine clinical use.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
